Europe
Clinical News
Informatics
Industry News
Practice Management
Education
Subspecialties
More
Sign In
CT
Digital X-Ray
Interventional
Molecular Imaging
MRI
Radiation Oncology/Therapy
Ultrasound
Womens Imaging
Molecular Imaging: Page 291
IBA, Piramal ink deal on F-18 amyloid imaging
By
AuntMinnie.com staff writers
Radiopharmaceutical provider IBA Molecular and Piramal Imaging have announced an agreement under which IBA will manufacture and distribute F-18 florbetaben, Piramal's new diagnostic imaging agent, in the European and U.S. markets.
August 6, 2012
Work-in-progress PET/MRI breast scanner finds tiny lesions
By
Wayne Forrest
While there is still much work ahead, breast MRI developer Aurora Imaging Technology and the Brookhaven National Laboratory say preliminary results from a work-in-progress PET/MRI breast scanner are promising, with the system detecting breast lesions smaller than 5 mm.
August 6, 2012
Alzheimer's disease: Reason for hope
By
Dr. Gregory Sorensen
When President Reagan welcomed women's basketball coach Pat Summitt to the White House 25 years ago, no one knew that Alzheimer's would someday become a thread connecting them. Fortunately, imaging now offers more certainty for those who may unknowingly have the disease, according to Siemens Healthcare CEO Dr. Gregory Sorensen.
August 5, 2012
Molecular Targeting licenses agent from MCW
By
AuntMinnie.com staff writers
Biotechnology developer Molecular Targeting Technologies has received an exclusive license from the Medical College of Wisconsin (MCW) for rights to a U.S. patent covering a technetium-99m radiopharmaceutical for noninvasive imaging of dead and dying cells.
August 1, 2012
SPECT/CT aids in tough endocarditis cases
By
AuntMinnie.com staff writers
The combination of SPECT/CT and white blood cells labeled with a technetium-99m radiopharmaceutical can improve the diagnosis of infectious endocarditis in difficult cases, according to a new study in the August issue of the
Journal of Nuclear Medicine
.
July 31, 2012
Navidea licenses Parkinson's imaging agent
By
AuntMinnie.com staff writers
Navidea Biopharmaceuticals has signed an agreement with Alseres Pharmaceuticals to license its iodine-123 radiolabeled agent, which is being developed to help diagnose Parkinson's disease and other movement disorders, with a potential use as a diagnostic aid in dementia.
July 31, 2012
MITA offers educational kits for PET
By
AuntMinnie.com staff writers
The Medical Imaging and Technology Alliance (MITA) has released its Demonstrating Excellence Through Advanced Imaging Learning (DETAIL) program, which provides resources for physicians and patients to learn about PET scans.
July 30, 2012
Naviscan brings PEM to Japan
By
AuntMinnie.com staff writers
PET developer Naviscan has received Shonin approval from the Japanese Ministry of Health, Labor, and Welfare to market its high-resolution PET technology, including its positron emission mammography (PEM) breast application.
July 30, 2012
Imaging of terminally ill rises; PEM for arthritis; history of radiation oncology
By
Brian Casey
July 30, 2012
RadNet centers to offer Amyvid PET scans
By
AuntMinnie.com staff writers
Imaging services firm RadNet plans to begin offering scans throughout its network with Amyvid, the PET radiopharmaceutical from Eli Lilly for the detection of Alzheimer's disease.
July 30, 2012
PETNet inks deal with Novation
By
AuntMinnie.com staff writers
Siemens Healthcare subsidiary PETNet Solutions has signed a five-year agreement to supply PET radiopharmaceuticals to group purchasing organization Novation.
July 30, 2012
Study shows PEM's potential in extremity imaging
By
Wayne Forrest
Positron emission mammography (PEM) is branching out from breast imaging, as researchers at Johns Hopkins University have used the modality with preliminary success to view osteoarthritis in patients' hand joints.
July 30, 2012
Previous Page
Page 291 of 611
Next Page